The relaxing effects of adenosine, N-[(R)-1-methyl-2 phenylethyll-adenosine (R-PIA) and 5-N-ethylcarboxamide adenosine (NECA) were investigated in human uterine arteries precontracted by phenylephrine in vitro. Adenosine, R-PIA and NECA relaxed isolated uterine arteries with intact endothelium, the potency order was NECA > R-PIA > adenosine. When tested on vessels devoid of their endothelium, the relaxing effect of adenosine was the same. These results suggest the vasodilatation effect on human uterine arteries is endothelium-independent, and might be via the A 2 receptor (by pharmacological classification). By administering adenosine to human uterine arterial cell culture, single cell intracellular calcium change was also determined by laser cytometry. Decreased intracellular calcium was observed after administration of adenosine 10" 6 M and 2X10"" 5 M. We concluded from the results that adenosine acts on human uterine artery cell by A2 receptor, independently of the endothelium, and decreases the intracellular calcium concentration, thus causing uterine artery relaxation.
Introduction
The uterine arteries are composed of the most important blood vessels supplying the human uterus, and are richly supplied by noradrenergic nerves (Owman and Stjernquist, 1988) . Noradrenaline contracts the human uterine artery in a dosedependent manner (Stjemquist and Owman, 1985) . Acetylcholine induces vasodilatation in endothelium intact vessel, and this relaxation effect has been proposed to be mediated via relaxing substances derived from the endothelium. Three such substances have been identified, i.e. the endotheliumderived relaxing factor (Furchgott, 1983) , now characterized as nitric oxide (Palmer et al, 1987) ; prostacyclin (Moncada et al, 1976) ; and the endothelium-derived hyperpolarization factor (Feletou and Vanhoutte, 1986 ). The endothelium-derived relaxing substances should be released when acetylcholine acts on muscarinic receptors on the endothelial cells. Other neurotransmitters which act by means of endothelium to induce uterine artery dilatation have been recently identified as substance P (SP), and vasoactive intestinal polypeptide (VIP). On the other hand, calcitonin gene-related peptide (CGRP) and atrial natriuretic peptide (ANP) act on the uterine vessel independently of the endothelium (Bodelsson and Stjemquist, 1992) .
Adenosine is a purine nucleoside of fundamental importance, serving as a building block in nucleic acid and as a regulator of biological function. Adenosine has recently been demonstrated to modulate the non-adrenergic non-cholinergic (NANC) neurotransmitter (Chiang et al, 1994) . It has a potent effect of vasodilatation, thereby increasing uterine artery blood flow in sheep (Resnik ef al, 1976) . However, to our knowledge, © European Society for Human Reproduction and Embryology the adenosine receptor or the relationship with endothelium in human uterine artery has seldom been investigated.
Therefore, the aim of the present study was to assess the pharmacological characterization of adenosine receptors in the human uterine artery in vitro. Additionally, endothelium and endothelium-denuded preparations were investigated to clarify whether the endothelium-dependent vasodilatation effect of adenosine is involved in the human uterine artery. For further study, the modulation of intracellular calcium by adenosine in a single uterine artery cell was determined with laser cytometry.
Materials and methods

Human material
Specimens of the ascending branch of the uterine artery were obtained from 40 women (mean age 48.2 years, range 40-66) undergoing abdominal hysterectomy for benign gynaecological diseases (endometriosis, fibromyoma, adenomyosis, menometrorrhagia). The patients received epidural anaesthesia with 2% xylocaine. Premedication was administered by use of atropine and demerol. Immediately following removal of the uterus, the helically formed ascending branches of the uterine arteries were identified on the lateral sides of the uterus. Segments of the vessel were excised and placed in cold (+4°C) Krebs-Ringer solution. We had provided the patients with detailed information regarding the purpose of this investigation and had obtained their consents for the excision of the specimens.
In-vttro pharmacology
Following excision, the vessels were transported to the laboratory immediately, where they were dissected free from adjacent veins and In the intact vessels ( + EC). the maximal contraction induced by phenylephrine (phenylephnne) 10" ? M (usually after 5 mm) was abolished by carbachol IO" S M. whereas the denuded vessels (-EC) did not respond to carbachol connective tissue They were cut into cylindrical segments with a length of 3-5 mm The circular specimens were placed in an organ chamber (volume 20 ml) between two platinum hooks, one of which was attached to a Grass FT03C force-displacement transducer and one of which could be moved to adjust the smooth muscle tension. The isometric tension was recorded on a Grass model 7D polygraph. The organ bath contained a modified Krebs-Ringer solution of the composition (in mM): NaCl 118. KC1 4.7. CaCN-2H 2 O 2.0. MgSO 4 7H : O 1 2. NaHCO, 24.8. KH : PO 4 I 2 and glucose 5 6 The specimens were mounted at 2 g resting tension in organ chambers containing Krebs-Ringer solution at 37°C. gassed with 95% O : and 5% CO 2 ; pH was maintained at 7 4-7.6. The drug was removed by several washes with Krebs-Ringer solution, and the tension was allowed to return to the baseline. Specimens were allowed to re-equilibrate for 30 mm after the drug response to ensure maximum wash-out of the drug as well as to minimize the possibility of receptor desensitization.
After an equilibration period of 1 h. the specimens were contracted by phenylephnne l()" s M. We removed the endothelium from 10 of the vessel preparations by two gentle injections of CWCOi gas mixture through the vessel lumen during 5 min at an interval of 10 min (Mikkelsene/a/., 1988; Bodelsson et al. 1989) . Another 10 untreated preparations acted as controls. Before a maximal vasoconstriction was elicited with phenylephnne (10" s M). we added carbamylchohne chloride (carbachol. If)" 5 M) for 5 min to ensure that the endothelium had been completely removed ( Figure I ) After washing, the preparations were contracted by an addition of 10 ' M phenylephnne When a stable contraction was established (after 5-10 min). adenosine (10~5 to 10"' M) was added to the organ chamber in a cumulative manner on both the intact and endothehum-denuded vessels to obtain a concentration-response curve. The higher dose was added when a stable muscle tension had been established, usually after 5 min Next, the potency of adenosine and adenosine agonist was investigated by adding adenosine 10" 5 to 10"' M. N-[(R)-l-methyl-2 phenylethyl)-adenosine (R-PIA) 10" K to I0" 5 M, 5-N-ethylcarboxamide adenosine (NECA) IO" K to 10^ M to the organ chamber in a cumulative manner on intact vessels.
Culture of cells
Vascular smooth muscle cells (VSMC) were isolated from utenne artenes by collagenase/elastase digestion (Davies el al., 1991) . The cells were grown on glass cover slips in medium 199 supplemented with 10% fetal calf serum, penicillin 100 lU/ml. and fungizone 2.5 ug/ml Positive identification of VSMC (>90%) was made possible by use of an o-smooth muscle actin immuno-fluorescent technique. The medium was changed even,' 2-3 days. Cells were passaged with trypsin and EDTA (0.5 g/1 and 0.2 g/l respectively) after confluence. Cells were subcultured into two or four chamber slides 1-2 days before the start of the expenment The cells selected for study of intracellular free calcium ([Ca 2 + )i) were firmly attached to the chamber slides and placed in areas with little cell debris in healthy cultures. We analysed data on single, well-separated cells that showed a normal response to phenylephrine. 
Measurements of [
Calculations and statistics
The percentage of relaxation refers to the decrease in phenylephnne induced tone. Data were expressed as means ± SEM. We estimated the concentration of the drug producing 50% of the relaxation (ED^n value) by use of a statistical package for the personal computer. Student's /-test was used for one or two samples to evaluate the possible significance, each expenment was performed only once on material from the same patient. The number of expenments was equal to the number of patients (n).
Results
Relaxing effect of adenosine in uterine artery with intact and denuded endothelium
Segments of uterine artery, with and without the presence of endothelium, were contracted with phenylephrine (10~5 M). Adenosine (10~5 to lO" 3 M), added cumulatively, relaxed both types of uterine artery in a dose dependent manner. Figure 2 reveals the dose-response curves for the action of adenosine in both preparations. Adenosine induced a relaxation of the isolated uterine arteries which was similar in intact and endothelium-denuded preparations (Table I) .
Effect of adenosine analogues in uterine artery
As shown in Table II. in the uterine artery in a dose-dependent manner. NECA were the most potent of the adenosine analogues tested. High doses of adenosine (5X10" 4 to 5XKT 3 M) elicited greater response than lower doses (10~5 to 5X10" 4 M). The ED 50 values of NECA, R-PIA and adenosine on the relaxation of contractions were 7.8 ± 1.3X1O" 7 M (n = 10), 4.8XKT 6 ± 4.5X10" 7 M (n = 10) and 6.34XKT 5 ± 8.9XKT
6 M (n = 10) respectively. The ratios of the ED 50 values of the other agonists relative to NECA were 6.2 for R-PIA and 81.3 for adenosine. Adenosine and its analogues caused inhibited contractile responses which were induced by phenylephrine with the potency order: NECA > R-PIA > adenosine (Table H) .
Relative intracellular calcium changes induced by adenosine
VSMC intracellular calcium concentrations increased 1.6-fold after exposure to IO" 6 M phenylephrine comparing to mean base line. Thereafter, adenosine 10" 6 M decreased [Ca 2+ ]i, by 1.3-fold compared to the base line. Cumulative administration of adenosine 2X10" 5 M brought [Ca 2+ ]i to the base level (Figure 4) .
Discussion
Although the vessel activity of human uterine arteries has been assumed to be controlled by noradrenaline and acetylcholine, other neurotransmitters, e.g. CGRP, VIP, SP, ANP, nitric oxide have been found to be involved in vessel relaxation. Also, CGRP, VIP, SP, nitric oxide have been proposed to act as NANC neurotransmitters (Ottesen et al, 1984; Kim et ai, 1991; Rajfer et al., 1992; Said, 1992) . As a local hormone, neurotransmitter, or neuromodulator, adenosine is an ubiquitous biological compound, being present in every cell of the human body. It is quite well established as an efficient local chemical regulatory signal that facilitates communication between cells and exerts a wide spectrum of effects on various tissues and organs under physiological and pathophysiological conditions (Wihlund et al, 1991) . In sheep uterine arteries, intra-arterial injection of adenosine (24 |iM) produces blood flows equal to those initiated by 1 ng of oestradiol-17(3 (0.24 ^M) (Resnik al., 1976) . However, little information is available regarding the effects of adenosine on human uterine arteries.
In our study, all adenosine and agonists exerted a vasodilatation effect on human uterine vessels and the potency for this relaxing effect was NECA > R-PIA > adenosine. Subclasses of adenosine receptors may be distinguished by the relative agonist potencies of certain adenosine analogues (Daly et al., 1985) . At the adenosine A2 receptor. NECA is more potent than R-PIA; whereas, R-PIA is equally or more potent than NECA at the Al receptor (Collis, 1983 : Gustafsson et al., 1985 Wihlund et al., 1986) . The agonist potency in human uterine arteries may be A 2 receptor dominant by pharmacological classification in our study. In adenosine A 2 receptors. NECA is at least 10-fold more potent than adenosine in rat brain (Daly, 1982) . In the present experiments, NECA revealed an 81.3-fold stronger potency than adenosine according to ED 50 The slope of the dose-response curve at high adenosine doses (5X 10" 4 to 5X 10" 1 M) is steeper than NECA and R-PIA. Though the reason for this is unclear, it may be that adenosine has different affinity to An receptors at different concentrations. Low dose (10~5 to 5XI0~5 M) adenosine showed almost parallel affinity to NECA and R-PIA. But, high-dose (5X 10-s to 5X 10" 3 M) adenosine elicited a greater response than did low-dose adenosine. The slope became even steeper than for NECA and R-PIA.
As shown in this study, adenosine induced dilatation independently of the endothelium, i.e. the same effect that has been reported for ANP and CGRP (Bodelsson and Stjernquist, 1992) . These regulatory substances seem to exert their effects on this vascular smooth muscle preparations without involving EDRF in the signal chain. Several lines of evidence have shown that adenosine does not require the presence of endothelial cells to elicit the relaxation of isolated arteries (Furchgott and Zawadzki. 1980; De Mey and Vanhoutte. 1981) . By contrast, endothelium-denuded preparations of pig aorta reduced the degree of relaxation produced by adenosine (Gordon and Martin. 1983) . Therefore it remains unclear whether the endothelium was related to the relaxing effect of adenosine or not, and it seems to be species and specimen specific. The present experimental results reveal that the relaxing effect of adenosine may be endothelium-independent (implying EDRFindependent) and may have a direct effect on the A : receptors of human uterine artery smooth muscle. Data have been obtained with a number of tissues indicating that adenosine A | receptor is associated with an inhibition of adenylate cyclase and a decrease in intracellular cyclic AMP (Linden, 1991) . A second subtype, the A : receptor, is associated with the stimulation of adenylate cyclase and an increase in cyclic AMP (vanCalkere/«/., 1979; Londos etal.. 1980 ). An increase in cAJvfP levels has long been associated with smooth muscle relaxation. Though the full mechanisms by which the cyclic nucleotides induce smooth muscle relaxation are still obscure, it is thought to lead to a reduction in intracellular calcium concentration, causing myosin dephosphorylation and relaxation (Torphy et al., 1986; Lincoln et al.. 1990; De Lanerolle and Paul, 1991) .
In our results, adenosine produced [Ca 2+ ]i decrease in a single uterine artery cell. Theoretically, the following possibilities might exist for the effect of adenosine on calcium: it may be indirect by (i) activation of cyclic nucleotide-dependent protein kinase. resulting in the lowering of [Ca :+ Ji concentration; (ii) decreasing the apparent affinity for calcium of an intracellular calcium receptor or site responsible for the release of transmitter; (iii) increasing the intracellular organelles" calcium sequestration; or (iv) by promoting calcium efflux. Otherwise, the effect may be direct by inhibiting the voltage-dependent calcium channel. Since the uterine artery is very important in human reproduction systems, mediation via multiple and complex pathways offers a major advantage: e.g. failure of the relaxant response is less likely than if only one mechanism existed, and the potential for augmentation of the relaxation is greatly enhanced. In the present study of adenosine acting on human uterine arteries, we have demonstrated that adenosine relaxed human uterine arteries by the A2 receptor, which is endothelium-independent. Incidentally, we have also presented the phenomenon that adenosine decreases [Ca 2+ ]i in a single human uterine artery cell. Further investigations are needed to reveal other mechanisms involving human uterine artery and adenosine.
